The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A single-arm, multicenter, phase II study of panitumumab in combination with capecitabine/oxaliplatin in first line, wild-type KRAS metastatic colorectal cancer patients.
 
Dimitrios G. Pectasides
No Relationships to Disclose
 
Vasilios Karavasilis
No Relationships to Disclose
 
Vassiliki Kotoula
No Relationships to Disclose
 
Epaminontas Samantas
No Relationships to Disclose
 
Zoi Alexopoulou
No Relationships to Disclose
 
Flora Zagouri
No Relationships to Disclose
 
Konstantinos N. Syrigos
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Novartis; Roche/Genentech
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Roche
 
Andreas Koureas
No Relationships to Disclose
 
Dimitrios Dionysopoulos
No Relationships to Disclose
 
Georgios Lazaridis
No Relationships to Disclose
 
Ioannis Efstratiou
No Relationships to Disclose
 
Dimitra Apessou
No Relationships to Disclose
 
George E. Pentheroudakis
No Relationships to Disclose
 
George Papaxoinis
No Relationships to Disclose
 
George Fountzilas
No Relationships to Disclose